• Coumestrol Drives PMAIP1-Linked Ferroptosis in RA FLS

  2026-09-23

  A recent cell-based study reports that Coumestrol suppresses proliferation and inflammatory output in rheumatoid arthritis fibroblast-like synoviocytes while promoting ferroptosis. Its proposed mechanism links reduced TRIM3-mediated protein turnover to increased mitochondrial PMAIP1 stability, although the findings do not yet establish efficacy in animals or patients.

• In Vitro Drug Response: Viability, Growth, and Cell Death

  2026-09-23

  Hannah R. Schwartz’s dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer drug response. Its central contribution is a framework for separating growth inhibition from cell killing and interpreting their different proportions and temporal relationships in vitro.

• H2S Deficiency and ER Stress in Diabetic Cardiomyopathy

  2026-09-22

  The reference study links reduced endogenous hydrogen sulfide production with cardiac lipotoxicity and endoplasmic reticulum stress in diabetic cardiomyopathy. By combining patient samples, a diabetic rat model, and palmitate-treated AC16 cardiomyocytes, it shows that hydrogen sulfide supplementation or ER-stress inhibition reduces lipid accumulation and apoptosis-related injury.

• Coumestrol: RA Ferroptosis Assay Workflow

  2026-09-22

  Coumestrol provides a versatile research entry point for connecting estrogen receptor biology with fibroblast-like synoviocyte proliferation, inflammation, mitochondrial stress, and ferroptosis. This workflow translates the latest rheumatoid arthritis findings into practical cell-based assays while addressing solubility, dose interpretation, receptor crosstalk, and reproducibility.

• Ibrexafungerp Against Resistant Candida auris

  2026-09-21

  The reference study shows that ibrexafungerp retained in vitro activity against fluconazole-resistant Candida auris and improved outcomes in a neutropenic mouse model even when treatment began after infection was established. Its combination of glucan synthase targeting, oral administration, and efficacy with delayed therapy provides a useful benchmark for antifungal development and comparative Candida research.

• 5-(N,N-dimethyl)-Amiloride: Endothelial Assay Guide

  2026-09-21

  Use 5-(N,N-dimethyl)-Amiloride hydrochloride to connect Na+/H+ exchanger activity with intracellular pH, sodium handling, and endothelial barrier behavior. This workflow translates sepsis-associated moesin findings into controlled perturbation experiments while preserving isoform-aware dosing and essential transport controls.

• Sulfo-NHS-LC-Biotin Protocol and QC Guide

  2026-09-20

  Sulfo-NHS-LC-Biotin provides a water-compatible way to covalently label accessible primary amines on proteins, peptides, and intact-cell surfaces for streptavidin capture or detection. It is appropriate for stable surface or protein labeling, but not for reversible tagging or intracellular labeling of cells with an intact plasma membrane.

• Ibrexafungerp vs Caspofungin in C. auris

  2026-09-19

  Wiederhold and colleagues combined isolate-level susceptibility testing with a delayed-treatment neutropenic mouse model to examine ibrexafungerp against fluconazole-resistant Candida auris. The findings support orally active glucan synthase inhibition as a promising strategy when therapy for invasive candidiasis cannot begin immediately, while also defining important limits for translation beyond the experimental model.

• Sulfo-NHS-LC-Biotin: Practical Labeling Guide

  2026-09-18

  Sulfo-NHS-LC-Biotin is a water-compatible reagent for permanent biotinylation of accessible primary amines on proteins, peptides, and intact cell surfaces. It is suited to streptavidin-based detection or capture, but not to reversible labeling or routine intracellular biotinylation because it is membrane-impermeable and forms irreversible amide bonds.

• Peptidisc-Assisted Nanobody Polybody Engineering

  2026-09-18

  Chen and Duong van Hoa describe a peptidisc-assisted hydrophobic clustering strategy that assembles nanobodies into soluble multimeric, bispecific, and autofluorescent polybodies. The approach uses a transmembrane segment to drive association and a peptidisc membrane mimetic to stabilize the resulting complexes, increasing apparent target binding through avidity while expanding nanobody engineering options.

• OSMI-1 for Reproducible OGT Inhibition Assays

  2026-09-17

  This scenario-based guide explains how OSMI-1 (SKU B7923) can support controlled O-GlcNAc transferase inhibition, viability testing, and mechanistic interpretation. It covers dosing, DMSO compatibility, target-engagement controls, safety, and practical supplier-selection criteria.

• Proteinase K as a Sample-Logic Enzyme

  2026-09-17

  Proteinase K is more than a genomic DNA isolation enzyme: its biochemical resilience can help researchers design cleaner, more interpretable sample-processing workflows. This article connects controlled protein hydrolysis with findings from a Candida albicans extracellular-vesicle study while defining practical limits and assay decisions.

• Dabigatran A4077: Reliable Thrombin Assays

  2026-09-16

  This scenario-based guide explains how Dabigatran, SKU A4077, can improve experimental control in thrombin inhibition and coagulation studies while avoiding common formulation and interpretation errors. It also clarifies the limits of extending coagulation findings into cell viability or cytotoxicity assays.

• Shrimp STING Reveals an Ancestral DNA-Sensing Axis

  2026-09-16

  The reference study demonstrates that shrimp STING can recognize both cytosolic double-stranded DNA and cyclic dinucleotides, linking nucleic-acid detection to an IFN-like antiviral program. Its identification of a dsDNA–STING–IKKε–IRF–Vago4 axis expands current models of innate immune evolution and provides a framework for studying antiviral signaling in arthropods.

• Reversible Surface Proteomics with Sulfo-NHS-SS-Biotin

  2026-09-15

  A mechanistic and translational guide to using Sulfo-NHS-SS-Biotin for reversible cell-surface labeling, affinity purification, and orthogonal validation of spatial protein interactions, with Notch receptor trafficking as a strategic case study.

8733 records 1/583 page Next 12345 下5页 Last page